BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18846392)

  • 1. Membranous glomerulonephritis: treatment response and outcome in children.
    Valentini RP; Mattoo TK; Kapur G; Imam A
    Pediatr Nephrol; 2009 Feb; 24(2):301-8. PubMed ID: 18846392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
    Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
    BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
    Muslimović A; Rasić S; Rebić D; Uncanin S
    Med Arh; 2009; 63(4):187-90. PubMed ID: 20088170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological feature and treatment of idiopathic membranous nephropathy in children].
    Wang X; Huang JP; Zhu BZ; Yao Y; Xiao HJ
    Zhonghua Er Ke Za Zhi; 2011 Apr; 49(4):311-5. PubMed ID: 21624211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy.
    Alexopoulos E; Sakellariou G; Memmos D; Karamitsos K; Leontsini M; Papadimitriou M
    Am J Kidney Dis; 1993 May; 21(5):497-503. PubMed ID: 8488817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
    Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
    Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
    Bruns FJ; Adler S; Fraley DS; Segel DP
    Ann Intern Med; 1991 May; 114(9):725-30. PubMed ID: 2012353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
    Bazzi C; Petrini C; Rizza V; Arrigo G; D'Amico G
    Kidney Int; 2000 Oct; 58(4):1732-41. PubMed ID: 11012907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis.
    Nasr SH; Said SM; Valeri AM; Stokes MB; Masani NN; D'Agati VD; Markowitz GS
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):299-308. PubMed ID: 19158367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and expression of PLA(2)R in renal tissue with idiopathic membranous nephropathy in children].
    Dong YF; Sun LW; Zhang B; Kuang XY; Niu XL; Kang YL; Hao S; Wang P; Li Z; Zhu GH; Huang WY; Wu Y
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):206-210. PubMed ID: 29518831
    [No Abstract]   [Full Text] [Related]  

  • 17. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus.
    Roberti I; Vyas S
    Pediatr Nephrol; 2010 Jun; 25(6):1117-24. PubMed ID: 20217433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.